People taking Eli Lilly and Co.'s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the medications.

The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...

Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing ...

Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that will further enhance the company's ...

Indianapolis: Eli Lilly and Company has announced executive leadership transitions affecting its US, Canada, International ...

Eli Lilly is investing more in its home state of Indiana, pumping up to $250 million more into an existing collaboration with ...

Eli Lilly and Purdue University announced a $250 million in what the two institutions say is the largest industry-academic partnership in the country.

Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...

Over the next eight years, Eli Lilly and Company and Purdue University will continue their partnership. According to an announcement on Friday morning, Lilly is expected to ...

Eli Lilly and Purdue University are expanding their partnership to improve drug discovery and manufacturing with a commitment of up to $250 million.